Apotex Europe Ltd & Ors v Beecham Group Plc & Anor [2003] EWHC 1395 (Pat) (06 June 2003)
The application to have the declarations of non-infringement tried with the existing actions was refused because GSK could not fairly be required to prepare for trial of the declarations on the expedited timetable, Apotex had not explained the delay in making the application, and the issues were already inherent in the upcoming trial. The risk of unfairness to GSK outweighed any benefit to Apotex.
- Citation
- [2003] EWHC 1395 (Pat)
- Parties
- Claimant: Apotex Europe Limited; Claimant: Neolab Limited; Claimant: Waymade Healthcare PLC; Defendant: Beecham Group PLC; Defendant: SmithKline Beecham PLC
- Jurisdiction
- England and Wales
- Judgment Date
- 06 June 2003
- Procedural Posture
- Application Within Patent Proceedings / Interlocutory Application for Joint Trial of Declaration of Non Infringement With Existing Actions
- Outcome
- Application refused
- Legal Topics
- Declaration of Non Infringement, Section 71 Patents Act 1977, Case Management, Joinder of Proceedings, Patent Infringement, Patent Validity
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
Apotex Europe Limited
Claimant
Neolab Limited
Claimant
Waymade Healthcare PLC
Claimant
Beecham Group PLC
Defendant
SmithKline Beecham PLC
Defendant
Procedural Posture
Application Within Patent Proceedings / Interlocutory Application for Joint Trial of Declaration of Non Infringement With Existing Actions
Legal Issues
- 1 Whether the application for declarations of non-infringement should be tried together with existing revocation and infringement actions
- 2 Whether the declarations sought are hypothetical and within the scope of section 71 of the Patents Act 1977
- 3 Whether it is fair and practicable to require the defendants to be ready for trial of the declarations on the expedited timetable
Ratio Decidendi
The application to have the declarations of non-infringement tried with the existing actions was refused because GSK could not fairly be required to prepare for trial of the declarations on the expedited timetable, Apotex had not explained the delay in making the application, and the issues were already inherent in the upcoming trial. The risk of unfairness to GSK outweighed any benefit to Apotex.
Court Disposition
Application refused
Orders
- Application to have the declarations of non-infringement tried with the other actions is refused
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment